Hasil Pencarian - Alessandro D’Avino

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Enhancing Oral 5-ASA Effectiveness in Mild-to-Moderate Ulcerative Colitis through an <i>H. erinaceus</i>-Based Nutraceutical Add-on Multi-Compound: The “HERICIUM-UC” Two-Arm Multicentre Retrospective Study

    Enhancing Oral 5-ASA Effectiveness in Mild-to-Moderate Ulcerative Colitis through an <i>H. erinaceus</i>-Based Nutraceutical Add-on Multi-Compound: The “HERICIUM-UC” Two-Arm Multic... oleh Antonio Tursi, Alessandro D’Avino, Giovanni Brandimarte, Giammarco Mocci, Raffaele Pellegrino, Edoardo Vincenzo Savarino, Antonietta Gerarda Gravina, the HERICIUM-UC Study Group

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Efficacy of a Fosfomycin-Containing Regimen for Treatment of Severe Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii: A Prospective, Observational Study

    Efficacy of a Fosfomycin-Containing Regimen for Treatment of Severe Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii: A Prospective, Observational Study oleh Alessandro Russo, Matteo Bassetti, Valeria Bellelli, Luigi Bianchi, Federica Marincola Cattaneo, Stefania Mazzocchetti, Elena Paciacconi, Fabrizio Cottini, Arcangelo Schiattarella, Giuseppe Tufaro, Francesco Sabetta, Alessandro D’Avino

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort

    The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: result... oleh Elena Raffetti, Maria Concetta Postorino, Francesco Castelli, Salvatore Casari, Filippo Castelnuovo, Franco Maggiolo, Elisa Di Filippo, Alessandro D’Avino, Andrea Gori, Nicoletta Ladisa, Massimo Di Pietro, Laura Sighinolfi, Fabio Zacchi, Carlo Torti

    Diterbitkan 2016-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial.

    Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results o... oleh Barbara Rossetti, Roberta Gagliardini, Genny Meini, Gaetana Sterrantino, Vincenzo Colangeli, Maria Carla Re, Alessandra Latini, Manuela Colafigli, Francesca Vignale, Stefano Rusconi, Valeria Micheli, Antonio Di Biagio, Giancarlo Orofino, Valeria Ghisetti, Alessandra Fantauzzi, Vincenzo Vullo, Pierfrancesco Grima, Daniela Francisci, Claudio Mastroianni, Andrea Antinori, Michele Trezzi, Lucia Lisi, Pierluigi Navarra, Benedetta Canovari, Antonella D'Arminio Monforte, Silvia Lamonica, Alessandro D'Avino, Maurizio Zazzi, Simona Di Giambenedetto, Andrea De Luca, for GUSTA trial study group

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: